LRRK2 and Parkinson disease: The PD-associated VPS35-p.D620N mutation, which affects the backbone VPS35 subunit of the retromer, has been shown by multiple groups to enhance LRRK2 kinase activity, although the underlying mechanism is incompletely understood [62–65].